AZN.UK

12,598

+1.32%↑

GSK

1,620

-1.7%↓

HLN.UK

331.8

+0.58%↑

STJ

1,293

+0.58%↑

AZN.UK

12,598

+1.32%↑

GSK

1,620

-1.7%↓

HLN.UK

331.8

+0.58%↑

STJ

1,293

+0.58%↑

AZN.UK

12,598

+1.32%↑

GSK

1,620

-1.7%↓

HLN.UK

331.8

+0.58%↑

STJ

1,293

+0.58%↑

AZN.UK

12,598

+1.32%↑

GSK

1,620

-1.7%↓

HLN.UK

331.8

+0.58%↑

STJ

1,293

+0.58%↑

AZN.UK

12,598

+1.32%↑

GSK

1,620

-1.7%↓

HLN.UK

331.8

+0.58%↑

STJ

1,293

+0.58%↑

Search

Hikma Pharmaceuticals PLC

Chiusa

SettoreSettore sanitario

1,841 0.82

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

1800

Massimo

1856

Metriche Chiave

By Trading Economics

Entrata

133M

Vendite

100M

1.7B

P/E

Media del settore

13.384

35.739

EPS

1.07

Rendimento da dividendi

5.06

Margine di Profitto

8.537

Dipendenti

9,500

EBITDA

-29M

259M

Raccomandazioni

By TipRanks

Raccomandazioni

Fortemente da comprare

Previsioni per 12 mesi

+37.72% upside

Dividendi

By Dow Jones

Rendimento da dividendi

Media del settore

5.06%

3.08%

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

-1.4B

3.7B

Apertura precedente

1840.18

Chiusura precedente

1841

Notizie sul Sentiment di mercato

By Acuity

41%

59%

120 / 371 Classifica in Healthcare

Hikma Pharmaceuticals PLC Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

1 ott 2025, 08:54 UTC

I principali Market Mover

Pharma Stocks in Europe Jump After White House Unveils Drug-Buying Site

8 apr 2025, 08:20 UTC

Discorsi di Mercato

Med-Tech Investors Seek 'Safe Havens' Amid Tariff Fears -- Market Talk

Confronto tra pari

Modifica del prezzo

Hikma Pharmaceuticals PLC Previsione

Obiettivo di Prezzo

By TipRanks

37.72% in crescita

Previsioni per 12 mesi

Media 2,472 GBX  37.72%

Alto 2,850 GBX

Basso 1,982 GBX

Basato su 6 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Hikma Pharmaceuticals PLC - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Fortemente da comprare

6 ratings

5

Acquista

1

Mantieni

0

Vendi

Sentiment

By Acuity

120 / 371 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Prove rialziste

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sotto la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Hikma Pharmaceuticals PLC

Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals. The Generics segment offers oral and other non-injectable generic products for the retail market. The Branded segment offers branded generics and in-licensed products to retail and hospital markets. The company provides its products in various therapeutic areas, including respiratory, oncology, and pain management. It also offers its products in solid, semi-solid, liquid, and injectable final dosage forms. The company operates in the United Kingdom, rest of Europe, North America, the Middle East, North Africa, and internationally. Hikma Pharmaceuticals PLC was founded in 1978 and is headquartered in London, the United Kingdom.
help-icon Live chat